Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA ...Middle East

PR Newswire - News
Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA
NANJING, China, Feb. 20, 2024 /PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a phase III clinical study (NCT04950920) (the "TASTE-SL Study") investigating Sanbexin® (a combination...

Hence then, the article about findings of a phase iii clinical study of sanbexin sublingual tablets published in jama was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA )

Apple Storegoogle play

Last updated :

Also on site :